Tag: obligation

Issued on behalf of GoldHaven Resources Corp.GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) completed a 2,320-line-kilometre district-scale airborne geophysical survey over its...

Issued on behalf of GoldHaven Resources Corp.GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) completed a 2,320-line-kilometre district-scale airborne geophysical survey over its...

Issued on behalf of Greenland Mines Ltd.Greenland Mines Ltd. (Nasdaq: GRML) has signed a diamond drilling contract with Arctic specialist Nordisk Fundering for a...

New analytics apps powered by NIQ's Expanded Omnishopper panel bring CPG brands visibility into shopper behavior — supporting cross-sell analysis, loyalty insights, and smarter...

Full Displacement of over 20-year incumbent Approximately 1,000 GPS tracking and house-arrest monitoring units with the opportunity to expandNEW YORK, June 25, 2026 /PRNewswire/...

CHARLOTTE, N.C., June 25, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) is pleased to announce that it has...

GENEVA, June 25, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics,...

Project delivered under a US$41 million transaction as part of the 21 MW DC Honeywell portfolio in upstate New York7.01 MW DC ground-mount solar...

Environmental, health, and safety solution is part of Veeva Quality Cloud and will deliver real-time insights and streamlined workflowsPLEASANTON, Calif., June 25, 2026 /PRNewswire/...

First underground core holes intersect a late silver-gold-copper event overprinting the principal polymetallic system, including 0.70 metres (true width) grading 4,604 g/t silver at...

Beam Global is relocating manufacturing from San Diego to Yuma, Arizona, reducing costs, improving margins, and supporting future growth.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY OTHER JURISDICTION WHERE TO DO SO WOULD VIOLATE...

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.